Shareholding disclosure

Black Creek Investment Management Inc

Declared position

4.71%

Threshold

Crossed upwards

Timeline

Published

11.03.2015

Transaction

05.03.2015

Transfer date

09.03.2015

Voting rights breakdown

Voting rights acquired4.71%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBF3900028

Beneficial owner

Black Creek Investment Management Inc

Declared address

Black Creek Investment Management Inc., Toronto, Ontario, M5H 1K5

Notification made voluntarily under Art. 9 para 2 SESTO-FINMA (DFC 2C_98/2013) Black Creek Investment Management Inc. is the investment manager of each of the Funds with discretionary voting authority over the shares of Basilea. Mr. Bill Kanko, 212 King Street West, Suite 500, Toronto, Ontario, Canada M5H 1K5, and Mr. Richard Jenkins, 212 King Street West, Suite 500, Toronto, Ontario, Canada M5H 1K5, as principals of Black Creek Investment Management Inc., each independently and indirectly control 36% of the voting shares of Black Creek Investment Management Inc., a privately held corporation.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Black Creek Investment Management Inc

Basilea Pharmaceutica AG, Allschwil11.03.2015TBF3900028

Disclosure summary

Black Creek Investment Management Inc disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the acquisition side, published by SIX Exchange Regulation on 11.03.2015, at 4.71% of voting rights. Notice category: Group of shareholders.

Disclosed position

4.71%

Voting rights acquired

Voting rights acquired4.71%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Black Creek Investment Management Inc disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 11.03.2015.

Publication date11.03.2015

Transaction date05.03.2015

Transfer date09.03.2015

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerBlack Creek Investment Management Inc

Declared addressBlack Creek Investment Management Inc., Toronto, Ontario, M5H 1K5

CategoryGroup of shareholders

Voting rights acquired4.71%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTBF3900028

Conditions

Notification made voluntarily under Art. 9 para 2 SESTO-FINMA (DFC 2C_98/2013) Black Creek Investment Management Inc. is the investment manager of each of the Funds with discretionary voting authority over the shares of Basilea. Mr. Bill Kanko, 212 King Street West, Suite 500, Toronto, Ontario, Canada M5H 1K5, and Mr. Richard Jenkins, 212 King Street West, Suite 500, Toronto, Ontario, Canada M5H 1K5, as principals of Black Creek Investment Management Inc., each independently and indirectly control 36% of the voting shares of Black Creek Investment Management Inc., a privately held corporation.

Source: SIX Exchange Regulation · Publication date: 11.03.2015

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open